EN

CN

Environmental, Social, and Governance

Environmental, Social, and Governance

The long-term value of a pharmaceutical company is not only reflected in business growth, but also in our responsible and sustainable contribution to human health and well-being.

Sustainable Development Philosophy

Gan & Lee Pharmaceuticals always upholds the sustainable development philosophy of "Patient First, Medicine for Good", and is committed to deeply integrating environmental, social, and governance (ESG) into the entire process of corporate strategy and business management. Focusing on the four strategic pillars of lean governance, health empowerment, green operations, and a people-oriented approach, we continuously enhance our overall ESG performance, and are dedicated to promoting medical equity, green development, and social prosperity.

ESG Performance

1.341billion CNY
R&D Investment
22.56 million CNY
Greenhouse Gas Emission Reduction Investment
0Incidents
Major Safety Accidents
51%
Female Employees
54%
Female Managers
0Incidents
Major Incidents of Graft and Corruption

Data source: Gan & Lee Pharmaceuticals 2025 Environmental, Social and Governance Report